Abstract
The aim of this article is to review the association between somatic symptoms, anxiety disorders and substance use. A Pub Med based literature review was conducted using various combinations of keywords related to substance use, somatic symptoms and anxiety. In various studies somatic symptoms were found to be associated with substance use. Anxiety disorders were found to have a high co-morbidity with substance use in most studies. However, several of the reviewed studies also included depressive symptoms which might have confounded the results. None of the studies was specifically aimed to find out if somatic symptoms in substance users represent an underlying primary anxiety disorder. Somatic symptoms and anxiety disorders are commonly noticed in substance users. Further studies are needed to clarify these associations since they may have significant clinical implications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd edn., Text Revision. Washington, American Psychiatric Association, 2000
Hasin D, Katz H: [Somatoform and substance use disorders]. Psychosomatic Medicine 69:870–875, 2007
Wedekind D, Engel K: Early detection of anxiety disorders. MMW Fortschritte der Medizin 149:32–35, 2007
Kirmayer LJ, Young A: Culture and somatization: Clinical, epidemiological, and ethnographic perspectives. Psychosomatic Medicine 60:420–430, 1998
Simon GE, VonKorff M, Piccinelli M, et al.: An international study of the relation between somatic symptoms and depression. New England Journal of Medicine 341:1329–1335, 1999
Marple RL, Kroenke K, Lucey CR, et al.: Concerns and expectations in patients presenting with physical complaints. Frequency, physician perceptions and actions, and 2-week outcome. Archives of Internal Medicine 157:1482–1488, 1997
Haug TT, Mykletun A, Dahl AA: The association between anxiety, depression, and somatic symptoms in a large population: The HUNT-II study. Psychosomatic Medicine 66:845–851, 2004
Kroenke K, Jackson JL, Chamberlin J: Depressive and anxiety disorders in patients presenting with physical complaints: Clinical predictors and outcome. American Journal of Medicine 103:339–347, 1997
P Kuo, H Yang: Substance use among adolescents in Taiwan: Associated personality traits, incompetence, and behavioral/emotional problems. Drug and Alcohol Dependence 67:27–39, 2002
Laukkanen ER, Shemeikka SL, Viinamaki HT, et al.: Heavy drinking is associated with more severe psychosocial dysfunction among girls than boys in Finland. Journal of Adolescent Health 28:270–277, 2001
Mowla A, Kianpor M, Bahtoee M, et al.: Comparison of clinical characteristics of opium-induced and independent major depressive disorder. American Journal of Drug and Alcohol Abuse 34:415–421, 2008
Tien AY, Schlaepfer TE: Self-reported somatization symptoms associated with risk for extreme alcohol use. Archives of Family Medicine 7:33–37, 1998
Kelly RH, Russo J, Katon W: Somatic complaints among pregnant women cared for in obstetrics: Normal pregnancy or depressive and anxiety symptom amplification revisited? General Hospital Psychiatry 23:107–113, 2001
Günther E: [Diagnosis and assessment of anxiety disorders]. Praxis. (Bern 1994) 87:731–734,1998
Walter M, Dammann G, Wiesbeck GA, et al.: [Psychosocial stress and alcohol consumption: Interrelations, consequences and interventions]. Fortschritte der Neurologie-Psychiatrie 73:517–525, 2005
Green CR, Flowe-Valencia H, Rosenblum L, et al.: The role of childhood and adulthood abuse among women presenting for chronic pain management. Clinical Journal of Pain 17:359–364, 2001
Feeney GF, Connor JP, Young RM, et al.: Cannabis dependence and mental health perception amongst people diverted by police after arrest for cannabis-related offending behaviour in Australia. Criminal Behaviour and Mental Health 15:249–260, 2005
Couvée JE, Bakker A, Zitman FG: The relevance of psychiatric and somatic comorbidity in depressed chronic benzodiazepine users. Psychotherapy and Psychosomatics 71:263–268, 2002
Langlitz N, Schotte K, Bschor, T: Loperamide abuse in anxiety disorder. Der Nervenarzt 72:562–564, 2001
Haver B: Female alcoholics. I. Psycho-social outcome six years after treatment. Acta Psychiatrica Scandinavica 74:102–111, 1986
Hague WH, Wilson LG: Post-detoxification drug treatment of anxiety and depression in alcohol addicts. Journal of Nervous and Mental Disease 162:354–359, 1976
van Balkom AJ, Beekman AT, de Beurs E, et al.: Comorbidity of the anxiety disorders in a community-based older population in The Netherlands. Acta Psychiatrica Scandinavica 111:401–402, 2005
T Pitkänen: Problem drinking and psychological well-being: A five-year follow-up study from adolescence to young adulthood. Scandinavian Journal of Psychology 40:197–207, 1999
Arnow BA, Hunkeler EM, Blasey CM, et al.: Comorbid depression, chronic pain, and disability in primary care. Psychosomatic Medicine 68:262–268, 2006
Rus-Makovec M, Cebasek-Travnik Z: Co-occurring mental and somatic diagnoses of alcohol dependent patients in relation to long-term aftercare alcohol abstinence and well-being. Psychiatria Danubina 20:194–207, 2008
Volipicelli JR, Clay KL: Naltrexone in the treatment of alcoholism: Predicting response to naltrexone. Journal of Clinical Psychiatry 56(Suppl 7):39–44, 1995
Sattar SP, Bhatia SC, Petty F: Potential benefits of quetiapine in the treatment of substance dependence disorders. Journal of Psychiatry and Neuroscience 29:452–457, 2004
Conflict of interest
The authors have no potential conflict of interest pertaining to this Psychiatric Quarterly submission.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hassan, I., Ali, R. The Association Between Somatic Symptoms, Anxiety Disorders and Substance Use. A Literature Review. Psychiatr Q 82, 315–328 (2011). https://doi.org/10.1007/s11126-011-9174-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11126-011-9174-2